{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:33:28Z","timestamp":1790699608904,"version":"4.1.0"},"reference-count":67,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Research on cervical cancer among WLWH represents a critical area for advancing long-term prevention and clinical management strategies. Yet as the volume of published literature in this field continues to grow rapidly, synthesizing and appraising the available evidence in a comprehensive manner has become increasingly challenging.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study aims to map the global research landscape, identify leading contributors and collaborative networks, and delineate the knowledge base and emerging research priorities in HIV-associated cervical cancer through a bibliometric analysis of multiple databases. Particular attention is given to the molecular and immunological mechanisms underlying the synergistic oncogenic interaction between HIV and high-risk HPV, as well as current trends in translational clinical research.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Publications on HIV and cervical cancer from January 1, 1990, to December 31, 2025 (n = 6,137) were retrieved and analyzed using bibliometric and visualization tools, including R (bibliometrix), Python, VOSviewer, and CiteSpace. Analyses encompassed publication trends, collaboration networks, keyword co-occurrence, and thematic evolution.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Research output has increased steadily, led by the United States, followed by China, South Africa, India, and the United Kingdom. The most productive journals include International Journal of Cancer and AIDS, which are also among the most frequently cited. The seminal reference is \u201cCancer-related Inflammation.\u201d Emerging research frontiers center on cervical cancer screening, WLWH, human papillomavirus vaccination, and deep learning.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Future directions will likely emphasize lifecycle vaccination strategies for WLWH, precision therapies guided by the immune microenvironment, and scalable screening approaches for low-resource settings. These findings provide evidence-based insights to inform global health policy and accelerate cervical cancer elimination efforts.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1835957","type":"journal-article","created":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T05:21:35Z","timestamp":1781068895000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Global research trends and hotspots in human immunodeficiency virus-associated cervical cancer (1990\u20132025): a multi-database bibliometric analysis"],"prefix":"10.3389","volume":"17","author":[{"given":"Lin","family":"Sui","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, West China Second Hospital of Sichuan University","place":["Chengdu, Sichuan, China"]},{"name":"Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, Sichuan University","place":["Chengdu, Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rutie","family":"Yin","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, West China Second Hospital of Sichuan University","place":["Chengdu, Sichuan, China"]},{"name":"Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, Sichuan University","place":["Chengdu, Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/s2214-109x(20)30459-9","article-title":"Estimates of the global burden of cervical cancer associated with HIV","volume":"9","author":"Stelzle","year":"2021","journal-title":"Lancet Global Health"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21696","article-title":"Cervical cancer prevention and control in women living with human immunodeficiency virus","volume":"71","author":"Castle","year":"2021","journal-title":"CA: A Cancer J For Clin"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.25110","article-title":"Evidence of synergistic relationships between HIV and human papillomavirus (HPV): systematic reviews and meta-analyses of longitudinal studies of HPV acquisition and clearance by HIV status, and of HIV acquisition by HPV status","volume":"21","author":"Looker","year":"2018","journal-title":"J Int AIDS Soc"},{"key":"B4","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1097\/qad.0000000000001765","article-title":"HIV-positive women have higher risk of human papilloma virus infection, precancerous lesions, and cervical cancer","volume":"32","author":"Liu","year":"2018","journal-title":"AIDS (Lond Engl)"},{"key":"B5","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/s0140-6736(07)61050-2","article-title":"Incidence of cancers in people with HIV\/AIDS compared with immunosuppressed transplant recipients: a meta-analysis","volume":"370","author":"Grulich","year":"2007","journal-title":"Lancet (Lond Engl)"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/92.22.1823","article-title":"Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults","volume":"92","year":"2000","journal-title":"J Natl Cancer Instit"},{"key":"B7","doi-asserted-by":"publisher","first-page":"10358","DOI":"10.3390\/ijms251910358","article-title":"Entangled connections: HIV and HPV interplay in cervical cancer-a comprehensive review","volume":"25","author":"Pavone","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B8","doi-asserted-by":"publisher","first-page":"001540","DOI":"10.1099\/jgv.0.001540","article-title":"The human papillomavirus oncoproteins: a review of the host pathways targeted on the road to transformation","volume":"102","author":"Scarth","year":"2021","journal-title":"J Gen Virol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3390\/ijms251910358","article-title":"Entangled connections: HIV and HPV interplay in cervical cancer\u2014a comprehensive review","volume":"25","author":"Pavone","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.3390\/microorganisms10051047","article-title":"Update on the epidemiological features and clinical implications of human papillomavirus infection (HPV) and human immunodeficiency virus (HIV) coinfection","volume":"10","author":"P\u00e9rez-Gonz\u00e1lez","year":"2022","journal-title":"Microorganisms"},{"key":"B11","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/j.chembiol.2024.02.004","article-title":"PROTAC-mediated degradation of HIV-1 Nef efficiently restores cell-surface CD4 and MHC-I expression and blocks HIV-1 replication","volume":"31","author":"Emert-Sedlak","year":"2024","journal-title":"Cell Chem Biol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"e93684","DOI":"10.1172\/jci.insight.93684","article-title":"Pharmacologic HIV-1 Nef blockade promotes CD8 T cell\u2013mediated elimination of latently HIV-1\u2013infected cells in vitro","volume":"2","author":"Mujib","year":"2017","journal-title":"JCI Insight"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0240154","article-title":"Depletion and activation of mucosal CD4 T cells in HIV infected women with HPV-associated lesions of the cervix uteri","volume":"15","author":"Mbuya","year":"2020","journal-title":"PloS One"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1012709","article-title":"Sustained immune activation and impaired epithelial barrier integrity in the ectocervix of women with chronic HIV infection","volume":"20","author":"Franz\u00e9n Boger","year":"2024","journal-title":"PloS Pathog"},{"key":"B15","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1007\/s00432-023-05531-2","article-title":"A visualization analysis of hotspots and global trends on pelvic floor dysfunction in cervical cancer","volume":"150","author":"Wang","year":"2024","journal-title":"J Cancer Res Clin Oncol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1186\/s12885-023-11345-9","article-title":"Regulatory T cell frequency in peripheral blood of women with advanced cervical cancer including women living with HIV","volume":"23","author":"Chetty-Sebastian","year":"2023","journal-title":"BMC Cancer"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1275270","article-title":"Deciphering the role of HPV-mediated metabolic regulation in shaping the tumor microenvironment and its implications for immunotherapy in HNSCC","volume":"14","author":"Gong","year":"2023","journal-title":"Front Immunol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2023.1194431","article-title":"Implications of viral infections and oncogenesis in uterine cervical carcinoma etiology and pathogenesis","volume":"14","author":"Chu","year":"2023","journal-title":"Front Microbiol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.4161\/cbt.5.6.2907","article-title":"The effects of HIV-1 Tat protein on cell cycle during cervical carcinogenesis","volume":"5","author":"Nyagol","year":"2006","journal-title":"Cancer Biol Ther"},{"key":"B20","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13027-022-00418-2","article-title":"HPV types 16\/18 L1 E6 and E7 proteins seropositivity and cervical cancer risk in HIV-positive and HIV-negative black South African women","volume":"17","author":"Singini","year":"2022","journal-title":"Infect Agents Cancer"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2016.4921","article-title":"Entrance of the Tat protein of HIV-1 into human uterine cervical carcinoma cells causes upregulation of HPV-E6 expression and a decrease in p53 protein levels","volume":"12","author":"Barillari","year":"2016","journal-title":"Oncol Lett"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3892\/ijo_00000064","article-title":"HIV-1 Tat enhances replicative potential of human oral keratinocytes harboring HPV-16 genome","volume":"33","author":"Kim","year":"2008","journal-title":"Int J Oncol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-026-03688-x","article-title":"Interstitial cystitis-related gene CCDC8 accelerates tumorigenesis by participating in CUL7-mediated degradation of P53 in bladder cancer","volume":"45","author":"Wang","year":"2026","journal-title":"Oncogene"},{"key":"B24","doi-asserted-by":"publisher","first-page":"680","DOI":"10.3390\/v16050680","article-title":"Human papillomavirus and associated cancers: a review","volume":"16","author":"Jensen","year":"2024","journal-title":"Viruses-Basel"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1612032","article-title":"T cell subsets in cervical cancer tumor microenvironment: advances and therapeutic opportunities","volume":"16","author":"Guo","year":"2025","journal-title":"Front Immunol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1101\/2024.07.10.24310202","article-title":"Cervical mucosal inflammation expands functional polymorphonuclear myeloid-derived suppressor cells","volume":"19","author":"Pieren","year":"2026","journal-title":"Mucosal Immunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.32491","article-title":"Human papillomavirus genotypes in cervical and other HPV-related anogenital cancer in Rwanda, according to HIV status","volume":"146","author":"Mpunga","year":"2020","journal-title":"Int J Cancer"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy575","article-title":"The efficacy of the quadrivalent human papillomavirus vaccine in girls and women living with human immunodeficiency virus","volume":"68","author":"McClymont","year":"2019","journal-title":"Clin Infect Dis"},{"key":"B29","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3390\/vaccines8010026","article-title":"HPV-specific systemic antibody responses and memory B cells are independently maintained up to 6 years and in a vaccine-specific manner following immunization with Cervarix and Gardasil in adolescent and young adult women in vaccination programs in Italy","volume":"8","author":"Nicoli","year":"2020","journal-title":"Vaccines"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.02.021","article-title":"Four-year persistence of type-specific immunity after quadrivalent human papillomavirus vaccination in HIV-infected children: effect of a fourth dose of vaccine","volume":"35","author":"Levin","year":"2017","journal-title":"Vaccine"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1097\/qad.0000000000001773","article-title":"Persistence of memory B-cell and T-cell responses to the quadrivalent HPV vaccine in HIV-infected children","volume":"32","author":"Weinberg","year":"2018","journal-title":"AIDS (Lond Engl)"},{"key":"B32","doi-asserted-by":"publisher","first-page":"e211740","DOI":"10.1001\/jamanetworkopen.2021.1740","article-title":"Point-of-care digital cytology with artificial intelligence for cervical cancer screening in a resource-limited setting","volume":"4","author":"Holmstr\u00f6m","year":"2021","journal-title":"JAMA Netw Open"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.2147\/ijwh.s474571","article-title":"The future of cervical cancer screening","volume":"16","author":"Goldstein","year":"2024","journal-title":"Int J Womens Health"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa1317","article-title":"Primary HPV and molecular cervical cancer screening in US women living with human immunodeficiency virus","volume":"72","author":"Strickler","year":"2021","journal-title":"Clin Infect Dis"},{"key":"B35","doi-asserted-by":"publisher","first-page":"ciae479","DOI":"10.1093\/cid\/ciae479","article-title":"Primary care guidance for providers who care for persons with human immunodeficiency virus: 2024 update by the HIV Medicine Association of the Infectious Diseases Society of America","author":"Horberg","year":"2024","journal-title":"Clin Infect Dis"},{"key":"B36","doi-asserted-by":"publisher","article-title":"WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention neWHO. WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention, 2nd Wed","year":"2021","DOI":"10.2471\/b09020"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1097\/01.ogx.0000549540.69362.81","article-title":"Screening for cervical cancer: US Preventive Services Task Force recommendation statement","volume":"320","author":"Curry","year":"2018","journal-title":"Jama"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.13174","article-title":"Self-collected vaginal specimens for human papillomavirus testing and guidance on screening exit: An update to the American Cancer Society cervical cancer screening guideline","volume":"76","author":"Perkins","year":"2026","journal-title":"CA: A Cancer J For Clin"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1097\/lgt.0000000000000195","article-title":"A randomized trial of human papillomavirus self-sampling as an intervention to promote cervical cancer screening among women with HIV","volume":"20","author":"Murphy","year":"2016","journal-title":"J Lower Genital Tract Dis"},{"key":"B40","doi-asserted-by":"publisher","first-page":"e0137299","DOI":"10.1371\/journal.pone.0137299","article-title":"Acceptability and accuracy of cervical cancer screening using a self-collected tampon for HPV messenger-RNA testing among HIV-infected women in South Africa","volume":"10","author":"Adamson","year":"2015","journal-title":"PloS One"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijgo.2008.10.009","article-title":"Cervical intraepithelial neoplasia recurrence after conization in HIV-positive and HIV-negative women","volume":"104","author":"Lima","year":"2009","journal-title":"Int J Gynaecol Obstetrics"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1097\/lgt.0000000000000525","article-title":"2019 ASCCP risk-based management consensus guidelines for abnormal cervical cancer screening tests and cancer precursors","volume":"24","author":"Perkins","year":"2020","journal-title":"J Low Genit Tract Dis"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1001\/archsurg.141.12.1238","article-title":"Surgical outcomes in human immunodeficiency virus\u2013infected patients in the era of highly active antiretroviral therapy","volume":"141","author":"Horberg","year":"2006","journal-title":"Arch Surg"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1136\/ijgc-2021-002601","article-title":"Chemoradiation versus radiation alone in stage IIIB cervical cancer patients with or without human immunodeficiency virus","volume":"31","author":"Grover","year":"2021","journal-title":"Int J Gynecol Cancer"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2004.11.006","article-title":"HIV infection and invasive cervical cancers, treatment with radiation therapy: toxicity and outcome","volume":"74","author":"Shrivastava","year":"2005","journal-title":"Radiother Oncol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1136\/ijgc-2021-002533","article-title":"Gynecological radiotherapy in people living with human immunodeficiency virus: a semi-systematic literature review","volume":"32","author":"Fenlon","year":"2022","journal-title":"Int J Gynecol Cancer"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2018.08.038","article-title":"Five-year overall survival following chemoradiation among HIV-positive and HIV-negative patients with locally advanced cervical carcinoma in a South African cohort","volume":"151","author":"Simonds","year":"2018","journal-title":"Gynecol Oncol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1080\/09540121.2017.1381332","article-title":"Exploring the views and experiences of HIV positive patients treated for cancer: a systematic review of the literature","volume":"30","author":"Hainsworth","year":"2018","journal-title":"AIDS Care"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1200\/go.21.00081","article-title":"Cervical cancer treatment in HIV-positive patients: a survey of treatment practices in India","volume":"7","author":"Mohanty","year":"2021","journal-title":"JCO Global Oncol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1080\/09540121.2025.2464618","article-title":"Association between mental health and substance use among reproductive-age women with HIV on cervical cancer screening and viral suppression outcomes","volume":"37","author":"Deaterly","year":"2025","journal-title":"AIDS Care"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2018.0033","article-title":"New NCCN guidelines: cancer management in people living with HIV","volume":"16","author":"Suneja","year":"2018","journal-title":"J Natl Compr Cancer Netw JNCCN"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdx220","article-title":"Cervical cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up\u2020","volume":"28","author":"Marth","year":"2017","journal-title":"Ann Oncol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu174","article-title":"Management of HIV infection in patients with cancer receiving chemotherapy","volume":"59","author":"Torres","year":"2014","journal-title":"Clin Infect Dis"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/s2352-3018(17)30149-2","article-title":"Association of antiretroviral therapy with high-risk human papillomavirus, cervical intraepithelial neoplasia, and invasive cervical cancer in women living with HIV: a systematic review and meta-analysis","volume":"5","author":"Kelly","year":"2018","journal-title":"Lancet HIV"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1086\/650467","article-title":"Influence of adherent and effective antiretroviral therapy use on human papillomavirus infection and squamous intraepithelial lesions in human immunodeficiency virus\u2014positive women","volume":"201","author":"Minkoff","year":"2010","journal-title":"J Infect Dis"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1200\/jco.24.00640","article-title":"Cancer immunotherapy trials network 12: pembrolizumab in HIV-associated kaposi sarcoma","volume":"43","author":"Lurain","year":"2025","journal-title":"J Clin Oncol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1200\/jco.23.00737","article-title":"Treating cancer in people with HIV","volume":"41","author":"Lurain","year":"2023","journal-title":"J Clin Oncol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1200\/jco.22.02459","article-title":"Safety and activity of immune checkpoint inhibitors in people living with HIV and cancer: a real-world report from the Cancer Therapy Using Checkpoint Inhibitors in People Living With HIV-International (CATCH-IT) Consortium","volume":"41","author":"El Zarif","year":"2023","journal-title":"J Clin Oncol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.mct-20-0055","article-title":"HIV protease inhibitors block HPV16-induced murine cervical carcinoma and promote vessel normalization in association with MMP-9 inhibition and TIMP-3 induction","volume":"19","author":"Qiu","year":"2020","journal-title":"Mol Cancer Ther"},{"key":"B60","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.3390\/v16101622","article-title":"Susceptibility of HPV-18 cancer cells to HIV protease inhibitors","volume":"16","author":"Makgoo","year":"2024","journal-title":"Viruses"},{"key":"B61","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.canlet.2015.04.027","article-title":"Nelfinavir, an HIV protease inhibitor, induces apoptosis and cell cycle arrest in human cervical cancer cells via the ROS-dependent mitochondrial pathway","volume":"364","author":"Xiang","year":"2015","journal-title":"Cancer Lett"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2016.5008","article-title":"The HIV-protease inhibitor saquinavir reduces proliferation, invasion and clonogenicity in cervical cancer cell lines","volume":"12","author":"Bandiera","year":"2016","journal-title":"Oncol Lett"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2022.875208","article-title":"Molecular mechanisms of HIV protease inhibitors against HPV-associated cervical cancer: Restoration of TP53 tumour suppressor activities","volume":"9","author":"Makgoo","year":"2022","journal-title":"Front Mol Biosci"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.7355","article-title":"Internal validation of Automated Visual Evaluation (AVE) on smartphone images for cervical cancer screening in a prospective study in Zambia","volume":"13","author":"Hu","year":"2024","journal-title":"Cancer Med"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1016\/s2214-109x(25)00352-3","article-title":"Performance of an artificial intelligence-based tool for cervical precancer screening in five countries in Africa: a prospective, observational, diagnostic accuracy study","volume":"14","author":"Barrett","year":"2026","journal-title":"Lancet Global Health"},{"key":"B66","doi-asserted-by":"publisher","first-page":"21772","DOI":"10.21203\/rs.3.rs-2389404\/v1","article-title":"Reproducible and clinically translatable deep neural networks for cervical screening","volume":"13","author":"Ahmed","year":"2023","journal-title":"Sci Rep"},{"key":"B67","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1038\/s41598-024-51880-4","article-title":"Development and validation of artificial intelligence-based analysis software to support screening system of cervical intraepithelial neoplasia","volume":"14","author":"Ouh","year":"2024","journal-title":"Sci Rep"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1835957\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T05:21:37Z","timestamp":1781068897000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1835957\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,10]]},"references-count":67,"alternative-id":["10.3389\/fimmu.2026.1835957"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1835957","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,10]]},"article-number":"1835957"}}